AngioDynamics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings
AngioDynamics, Inc. (ANGO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings of $33.00 thousand for the 6-month period ending 2018-11-30, per its 10-Q filed 2019-01-07.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 · last filed 2019-01-07
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2018-02-28 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2017-11-30 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2017-05-31 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for the quarter ending 2017-02-28 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2017 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2016 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2015 was $0.00.
- AngioDynamics, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in earnings for fiscal 2014 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2018-11-30 | $33.00K 10-Q · filed 2019-01-07 | |||
| 2018-02-28 | $0.00 10-Q · filed 2018-04-05 | $0.00 derived: sum of 2 quarters · filed 2018-04-05 | ||
| 2017-11-30 | $0.00 10-Q · filed 2018-01-05 | |||
| 2017-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-23 | $0.00 derived: sum of 2 quarters · filed 2018-07-23 | $0.00 derived: sum of 3 quarters · filed 2018-07-23 | $0.00 10-K · filed 2018-07-23 |
| 2017-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-03 | $0.00 derived: sum of 2 quarters · filed 2017-04-03 | $0.00 10-Q · filed 2017-04-03 | |
| 2016-11-30 | $0.00 10-Q · filed 2017-01-06 | $0.00 10-Q · filed 2017-01-06 | ||
| 2016-05-31 | $0.00 10-K · filed 2017-08-04 | |||
| 2015-05-31 | $0.00 10-K · filed 2016-08-01 | |||
| 2014-05-31 | $0.00 10-K · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |